Font Size: a A A

Business Analysis And Improvement Of Realcan Pharmaceutical Group Co.,Ltd. Accounts Receivable Asset-backed Securitization

Posted on:2020-08-25Degree:MasterType:Thesis
Country:ChinaCandidate:S R ZouFull Text:PDF
GTID:2439330575469820Subject:Business Administration
Abstract/Summary:PDF Full Text Request
Medicine and medical device distribution companies are important commercial organizations that connect manufacturing companies and medical institutions.With the continuous deepening of China's medical reform,medicine and medical device distribution enterprises play an increasingly important role in China's medical and health fields.Funding is one of the most important factors for the healthy development of medicine and medical device distribution companies.How to integrate more stable funds is a common problem faced by such enterprises.Drugs and medical device distribution companies have formed a large number of high-quality accounts receivable in the business development.How to revitalize this part of the accounts receivable and make them cash in advance has become an important target for corporate financing in the industry.The asset-backed securitization business is a process in which an asset holder converts assets into cash by transferring assets in a structured manner after the assets are structured.Therefore,the asset securitization business is an effective means of revitalizing the accounts receivable of medicine and medical device distribution enterprises.In recent years,the asset securitization business has entered a period of rapid development,and the market capacity has expanded rapidly,forming an emerging trillion-level financing market.In November 2017,Realcan Pharmaceutical Group Co.,Ltd.issued a single account receivable asset-backed securitization business,which provided a better case for the revitalization of accounts receivable in the industry.Through the literature research method,case analysis research method and comparative research method,this paper conducts an in-depth study on the asset-backed securitization business issued by Realcan Pharmaceutical Group Co.,Ltd..Firstly,this paper describes the development status of asset securitization business at home and abroad,and introduces the theory of asset securitization business.Secondly,this paper analyzes the external environment and internal demand of the company's asset securitization,and The case design of the case is described,comparing the changes in the company's financial data before and after the case is released,and comparing with the financial data of the same industry,discovering the advantages and current deficiencies of the asset-backed securitization business;again,through risk screening and risk assessment Risk prevention and other three aspects analyze the risk situation of the business,and propose optimization suggestions for the problems found in the company's asset-backed securitization business process.Finally,summarize the asset-backed securitization to improve the company's financial data and enhance the company's open market image.There are obvious advantages in reducing financing costs,etc.,and prospects for the future development of asset securitization business.
Keywords/Search Tags:Realcan Pharmaceutical Group Co.,Ltd., Accounts receivable, Asset-backed securitization
PDF Full Text Request
Related items